Skip to main content

Access to Essential Cancer Medicines

Course description
The purpose of this course is to review the landscape and challenges related to access to essential cancer medicines especially in low and middle-income (LMIC) countries and discuss methodologies for evaluating medicine availability and approaches to ensuring access, availability and mitigating medicine stock-outs.

Course learning objectives
At the end of this course, participants will be able to:

  • Describe the current landscape of essential cancer medicines and diagnostics related to access and availability, with a focus on LMICs.
  • Examine measures and definitions of access to cancer medicines and diagnostics and its impact on clinical health outcomes.
  • Report on potential solutions to mitigating lack of access to cancer therapy.
  • Provide a holistic evaluation of cancer medicine access, including factors unrelated to medicine price.
Target audience
The course is targeted towards providers who prescribe and administer chemotherapy and agencies involved in formulation, procurement and supply of national essential medicines for cancer treatment in developing countries.

Participants are expected to have some level of work experience and knowledge of health systems and health financing.

This course is delivered exclusively in English.